Furthermore, down-regulating the expression of endogenous MRPL12, MRPL13 or POP1 in breast cancer cells, resulted in dramatically suppression of cellular viability and migration, suggesting that these three RBP-coding genes might act as oncogenes in accelerating the progress of breast cancer (Figures 8, 9). This evidence concerns the gene MRPL13 and breast carcinoma.